The treatment of hematologic malignancies in pregnancy

por Vandenbriele, C., Dierickx, D., Amant, F., Delforge, M.
Publicado 2010

P.067 Real-time PCR for the detection of respiratory viruses

por Seffar, M., Brancart, F., Vincart, B., Quenon, P., de Leener, A., Delforge, M.L., Liesnard, C.
Publicado 2009

Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff

por Martin, C., Montesinos, I., Dauby, N., Gilles, C., Dahma, H., Van Den Wijngaert, S., De Wit, S., Delforge, M., Clumeck, N., Vandenberg, O.
Publicado 2020

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

por Platzbecker, U, Symeonidis, A, Oliva, E N, Goede, J S, Delforge, M, Mayer, J, Slama, B, Badre, S, Gasal, E, Mehta, B, Franklin, J
Publicado 2017

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

por Mateos, M, Leleu, X, Zamagni, E, Delforge, M, Bringhen, S, Broijl, A, de la Rubia, J, Shaw, A, Brescianini, A, Gonzalez-McQuire, S, Patel, S, Moreau, P
Publicado 2022

P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL-WORLD OUTCOMES FOR STANDARD OF CARE

por Vekemans, M-C, Delforge, M, Anguille, S, Depaus, J, Meuleman, N, Van de Velde, A, Vande Broek, I, Strens, D, Van Hoorenbeeck, S, Moorkens, EJ, Diels, J, Ghilotti, F, Dalhuisen, S, Vandervennet, S
Publicado 2022

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE L...

por Einsele, H., Moreau, P., Delforge, M., van de Donk, N. W., Ghilotti, F., Diels, J., Elsada, A., Strulev, V., Pei, L., Kobos, R., Smit, J., Slavcev, M., Weisel, K., Mateos, M.-V.
Publicado 2022

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

por Dimopoulos, M A, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, G J, Davies, F E, Sonneveld, P, Schey, S A, Zweegman, S, Hansson, M, Weisel, K, Mateos, M V, Facon, T, Miguel, J F S
Publicado 2014

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel

por Caers, J., Paiva, B., Zamagni, E., Leleu, X., Bladé, J., Kristinsson, S. Y., Touzeau, C., Abildgaard, N., Terpos, E., Heusschen, R., Ocio, E., Delforge, M., Sezer, O., Beksac, M., Ludwig, H., Merlini, G., Moreau, P., Zweegman, S., Engelhardt, M., Rosiñol, L.
Publicado 2018

P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS...

por Einsele, H, Cohen, AD, Delforge, M, Hillengass, J, Goldschmidt, H, Weisel, K, Raab, M-S, Scheid, C, Schecter, JM, De Braganca, KC, Varsos, H, Yeh, T-M, Wang, L, Vogel, M, Corsale, C, Akram, M, Pacaud, L, Nesheiwat, T, Agha, M, Cohen, YC
Publicado 2022

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND E...

por van de Donk, NWCJ, Delforge, M, Agha, M, Cohen, AD, Cohen, YC, Hillengass, J, Anguille, S, Kerre, T, Roeloffzen, W, Schecter, JM, De Braganca, KC, Varsos, H, Wang, L, Vogel, M, Zudaire, E, Corsale, C, Akram, M, Geng, D, Nesheiwat, T, Pacaud, L, Sonneveld, P, Zweegman, S
Publicado 2022

P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STUDY OF REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

por Delforge, M., Moreau, P., Einsele, H., De Stefano, V., Lindsey-Hill, J., Vincent, L., Mangiacavalli, S., Perrot, A., Ocio, E., ten Seldam, S., ’. Groen-Damen, E. I., Semerjian, M., Strulev, V., Schecter, J. M., Roccia, T., Gries, K. S., Nesheiwat, T., Wapenaar, R., Mateos, M.-V., Weisel, K.
Publicado 2022

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES...

por Hillengass, J., Cohen, A. D., Delforge, M., Einsele, H., Goldschmidt, H., Weisel, K., Raab, M.-S., Scheid, C., Schecter, J. M., De Braganca, K. C., Varsos, H., Yeh, T.-M., Mistry, P., Roccia, T., Corsale, C., Akram, M., Pacaud, L., Nesheiwat, T., Agha, M., Cohen, Y. C.
Publicado 2022

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE: SUBGROUP...

por Facon, T., Plesner, T., Usmani, S., Kumar, S., Bahlis, N., Hulin, C., Orlowski, R., Nahi, H., Mollee, P., Ramasamy, K., Roussel, M., Jaccard, A., Delforge, M., Karlin, L., Arnulf, B., Chari, A., Pei, H., Gupta, N., Kaila, S., Matt, K., Gries, K., Carson, R., Borgsten, F., Weisel, K., Perrot, A.
Publicado 2023

P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMP...

por Delforge, M., Usmani, S. Z., van de Donk, N. W., Garfall, A. L., Moreau, P., Oriol, A., Nooka, A. K., Rosinol, L., Bahlis, N., Rodriguez-Otero, P., Martin, T., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Krishnan, A.
Publicado 2022

Late presentation to HIV testing is overestimated when based on the consensus definition

por Sasse, A, Florence, E, Pharris, A, De Wit, S, Lacor, P, Van Beckhoven, D, Deblonde, J, Delforge, M‐L, Fransen, K, Goffard, J‐C, Legrand, J‐C, Moutschen, M, Piérard, D, Ruelle, J, Vaira, D, Vandercam, B, Van Ranst, M, Van Wijngaerden, E, Vandekerckhove, L, Verhofstede, C
Publicado 2015

PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON

por Rosinol, L., Usmani, S. Z., Bahlis, N., Krishnan, A. Y., Nooka, A. K., Oriol, A., Delforge, M., Garfall, A. L., van de Donk, N. W., Rodríguez Otero, P., Martin, T. G., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Moreau, P.
Publicado 2022

P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1

por Popat, R., Moreau, P., Usmani, S. Z., Garfall, A., Mateos, M.-V., San-Miguel, J. F., Oriol, A., Nooka, A. K., Rosinol, L., Chari, A., Karlin, L., Krishnan, A., Bahlis, N., Martin, T., Besemer, B., Martínez-López, J., Delforge, M., Fastenau, J., Gries, K. S., van de Donk, N. W.
Publicado 2022

B08 IDECABTAGENE VICLEUCEL VERSUS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA: KARMMA-3 A PHASE 3 RANDOMIZED CONTROLLED TRIAL...

por Rodríguez-Otero, P., Ailawadhi, S., Arnulf, B., Patel, K., Cavo, M., Nooka, A.K., Manier, S., Callander, N., Costa, L.J., Vij, R., Bahlis, N.J., Moreau, P., Solomon, S.R., Delforge, M., Berdeja, J., Truppel-Hartmann, A., Yang, Z., Favre-Kontula, L., Wu, F., Piasecki, J., Cook, M., Giralt, S.
Publicado 2023

P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS

por Avivi, I., H vesole, D., Dávila Valls, J., Usnarska-Zubkiewicz, L., Milunovic, V., Bogumiła Osękowska, B. B., Kopińska, A., Gentile, M., MARTÍNEZ, B. P., Robak, P., crusoe, E., LUIS GERARDO, R., Gajewska, M., Gergely, V., Delforge, M., Cohen, Y., Alessandro, G., peña, C., Shustik, C., Mikala, G., Žalac, K., Denis, A. H., Peter, B., Weisel, K., martinez lopez, J., Waszczuk-Gajda, A., Krzystanski, M., Jurczyszyn, A.
Publicado 2022